These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 17287639

  • 1. Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome.
    Coppola A, Simone CD, Palmieri NM, Coppola D, Lanza F, Ruosi C, Amoriello A, Di Minno G.
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):199-201. PubMed ID: 17287639
    [Abstract] [Full Text] [Related]

  • 2. [Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia].
    Zotz RB, Scharf RE.
    Hamostaseologie; 2007 Sep; 27(4):251-62. PubMed ID: 17938763
    [Abstract] [Full Text] [Related]

  • 3. To general haemostasis--the evidence-based route.
    Erhardtsen E.
    Pathophysiol Haemost Thromb; 2002 Sep; 32 Suppl 1():47-52. PubMed ID: 12214148
    [Abstract] [Full Text] [Related]

  • 4. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB, Patnaik M.
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [Abstract] [Full Text] [Related]

  • 5. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U, Erhardtsen E.
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
    Erduran E, Aksoy A, Zaman D.
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):215-7. PubMed ID: 19657319
    [Abstract] [Full Text] [Related]

  • 9. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
    Galán AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G.
    Transfusion; 2003 Jul; 43(7):885-92. PubMed ID: 12823748
    [Abstract] [Full Text] [Related]

  • 10. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia.
    Lombardo VT, Sottilotta G.
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):115-6. PubMed ID: 16444446
    [Abstract] [Full Text] [Related]

  • 11. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation.
    Gerotziafas GT, Zervas K, Arzoglou P, Karavaggeli E, Parashou S, Van Dreden P, Christakis J, Samama MM.
    Br J Haematol; 2002 Jun; 117(3):705-8. PubMed ID: 12028045
    [Abstract] [Full Text] [Related]

  • 12. The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders.
    Poon MC.
    Transfus Med Rev; 2007 Jul; 21(3):223-36. PubMed ID: 17572261
    [Abstract] [Full Text] [Related]

  • 13. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [Abstract] [Full Text] [Related]

  • 14. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A.
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
    Poon MC, D'Oiron R, Von Depka M, Khair K, Négrier C, Karafoulidou A, Huth-Kuehne A, Morfini M, International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group.
    J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
    [Abstract] [Full Text] [Related]

  • 16. Tissue factor-independent effects of recombinant factor VIIa on hemostasis.
    Weeterings C, Lisman T, de Groot PG.
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S12-5. PubMed ID: 18544417
    [Abstract] [Full Text] [Related]

  • 17. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [Abstract] [Full Text] [Related]

  • 18. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.
    Tranholm M, Rojkjaer R, Pyke C, Kristensen AT, Klitgaard B, Lollike K, Blajchman MA.
    Thromb Res; 2003 Feb 15; 109(4):217-23. PubMed ID: 12757777
    [Abstract] [Full Text] [Related]

  • 19. Congenital and acquired platelet disorders: current dilemmas and treatment strategies.
    White GC.
    Semin Hematol; 2006 Jan 15; 43(1 Suppl 1):S37-41. PubMed ID: 16427384
    [Abstract] [Full Text] [Related]

  • 20. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
    Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.
    Am J Hematol; 2002 Mar 15; 69(3):219-22. PubMed ID: 11891811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.